Methimazole-induced Cholestatic Jaundice

Southern Medical Journal

Volumn 97, Issue 2, 2004, Pages 178-182

  Mikhail, Nasser E ^a  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; PROPRANOLOL; THIAMAZOLE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPERTHYROIDISM; LABORATORY TEST; LIVER FUNCTION TEST; OBSTRUCTIVE JAUNDICE; PRURITUS; TREATMENT OUTCOME;

ADULT; AGED; ANTITHYROID AGENTS; FEMALE; HUMANS; JAUNDICE, OBSTRUCTIVE; MALE; METHIMAZOLE; MIDDLE AGED; PRURITUS;

EID: 1242314244     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000054690.98272.B1     Document Type: Article

References (36)

1. Stanley MM, Astwood EB. 1-methyl-2-mercaptoimidazole: An antithyroid compound highly active in man. Endocrinology 1949;44:588-589.
2. Kampmann JP, Hansen JM. Clinical pharmacokinetics of antithyroid drugs. Clin Pharmacokinet 1981;6:401-428.
3. Cooper DS. Treatment of thyrotoxicosis, in Braveman LE, Utiger RD (eds): Werner and Ingbars The Thyroid. Philadelphia, Lippincott-Raven, 1996, ed 7, pp 713-734.
4. Specht NW, Boehme EJ. Death due to agranulocytosis induced by methimazole therapy. JAMA 1952;149:1010-1011.
5. Rosenbaum H, Reveno WS. Agranulocytosis and toxic hepatitis from methimazole. JAMA 1953;152:27.
6. Shipp J. Jaundice during methimazole (Tapazole) administration. Ann Intern Med 1955;42:701-706.
7. Tennenbaum JI, Dreskin H. Toxic hepatitis during treatment with methimazole (Tapazole): Report of a case with apparent recovery. Ohio State Med J 1962;58:306-307.
8. Martinez-Lopez JI, Greenberg SE, Kling R. Drug-induced hepatic injury during methimazole therapy. Gastroenterology 1962;43:84-87.
9. Becker CF, Gorden P, Robbins J. Hepatitis from methimazole during adrenal steroid therapy for malignant exophthalmos. JAMA 1968;206:1787-1789.
10. Fisher MG, Nayer HR, Miller A. Methimazole-induced jaundice. JAMA 1973;223:1028-1029.
11. Jansen PL, Froeling PG, Schade RW, et al. Intrahepatic cholestasis in hyperthyroidism and the effect of antithyroid and β-blocking drugs. Neth J Med 1982;25:318-324.
12. Schmidt G, Borsch G, Muller KM, et al. Methimazole-associated liver injury: Case report and brief literature review. Hepatogastroenterology 1986;33:244-246.
13. Arab D, Malatjalian DA, Rittmaster RS, Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J Clin Endocrinol Metab 1995;80:1083-1085.
14. Schwab GP, Wetscher GJ, Vogl W, et al. Methimazole-induced liver injury, mimicking sclerosing cholangitis. Langenbecks Arch Chir 1996;381:225-227.
15. Prost G, Dechavanne M, Levenq P, et al. Cholestatic jaundice caused by carbimazole [in French]. Nouv Presse Med 1973;2:2479 (letter).
16. Dinsmore WW, O'Hara MD, Callender ME. Postanesthetic carbimazole jaundice. N Engl J Med 1983;309:438 (letter).
17. Blom H, Stolk J, Schreuder HB, et al. A case of carbimazole-induced intrahepatic cholestasis. An immune-mediated reaction? Arch Intern Med 1985;145:1513-1515.
18. Ayensa C, Diaz De Otazo R, Cia JM. Carbimazole-induced cholestatic hepatitis. Arch Intern Med 1986;146:1455 (letter).
19. Epeirier JM, Pageaux GP, Coste V, et al. Fulminant hepatitis after carbimazole and propranolol administration. Eur J Gastroenterol Hepatol 1996;8:287-288.
20. Cales P, Voigt JJ, Suduca JM, et al. Cholestatic jaundice caused by carbimazole [in French]. Presse Med 1987;16:1005.
21. Ozenne G, Manchon ND, Doucet J, et al. Carbimazole-induced cholestatic jaundice. J Clin Gastroenterol 1989;11:95-97.
22. Sadoul JL, Canivet B, Freychet P. Toxic hepatitis induced by antithyroid drugs: Four cases including one with cross-reactivity between carbimazole and benzylthiouracil. Eur J Med 1993;2:473-477.
23. Kang H, Choi JD, Jung IG, et al. A case of methimazole-induced acute hepatic failure in a patient with chronic hepatitis B carrier. Korean J Intern Med 1990;5:69-73.
24. Baker B, Shapiro B, Fig LM, et al. Unusual complications of antithyroid drug therapy: Four case reports and review of literature. Thyroidology 1989;1:17-26.
25. Lunzer M, Huang S, Ginsburg J, et al. Jaundice due to carbimazole. Gut 1975;16:913-917.
26. Yao JD, Gross JB Jr, Ludwig J, et al. Cholestatic jaundice in hyperthyroidism. Am J Med 1989;86:619-620.
27. Lersch C, Seige M, Natrath W, et al. Cholestasis induced by hyperthyroidism after liver transplantation. Digestion 1995;56:429-432.
28. Babini G, Gurioli L, Rizzi R, et al. Appearance of severe jaundice after radiometabolic treatment of thyrotoxicosis. J Endocrinol Invest 1999;22:209-211.
29. Anton Aranda A. Intrahepatic cholestasis in untreated hyperthyroidism [in Spanish]. Rev Esp Enferm Dig 2000;92:49-50.
30. Scanlon MF, Toft AD. Regulation of thyrotropin secretion, in Braveman LE, Utiger RD (eds): Werner and Ingbars The Thyroid. Philadelphia, Lippincott-Raven, 1996, ed 7, pp 220-240.
31. Ozenirler S, Tuncer C, Boztepe U, et al. Propylthiouracil-induced hepatic damage. Ann Pharmacother 1996;30:960-963.
32. Eisen MJ. Fulminant hepatitis during treatment with propylthiouracil. N Engl J Med 1953;249:814-816.
33. Maggiore G, Larizza D, Lorini R, et al. Propylthiouracil hepatotoxicity mimicking autoimmune chronic active hepatitis in a girl. J Pediatr Gastroenterol Nutr 1989;8:547-548.
34. Cooper DS, Bodes HH, Nath B, et al. Methimazole pharmacology in man: Studies using a newly developed radioimmunoassay for methimazole. J Clin Endocrinol Metab 1984;58:473-479.
35. Methimazole, in Murray L (ed): Product Drug Reference. Montvale, NJ, Medical Economics Co., 2002, ed 56, pp 1823-1824.
36. Huang M, Li K, Wei JS, et al. Sequential liver and bone biochemical changes in hyperthyroidism: Prospective controlled follow-up study. Am J Gastroenterol 1994;89:1071-1076.